Abstract
This systematic review aimed to synthesize current evidence on the effects of electronic cigarette (EC) use on pulmonary function and vocal outcomes in adult smokers, compared with conventional tobacco smoking. The review followed PRISMA (2020) guidelines and was registered in PROSPERO (CRD420251166920). A structured PICO question guided searches conducted in PubMed, LILACS, Web of Science, BVS and Embase, covering the last ten years. Studies addressing EC use and its pulmonary or phonatory repercussions in adults were included. Methodological quality was assessed using the NHLBI tools. Due to substantial heterogeneity across studies, meta-analysis was not performed. From 696 records, four studies met the eligibility criteria. Overall, EC exposure was associated with pulmonary alterations including airway inflammation, mucociliary clearance impairment, and histological changes in alveolar tissue. Evidence also indicated potential effects on the phonatory system, such as epithelial irritation of the vocal folds, increased vocal symptoms (hoarseness, vocal fatigue, throat dryness), and mild deviations in acoustic measures. Although the pulmonary consequences of EC use were more consistently documented, data regarding vocal outcomes remain limited. Two studies demonstrated good methodological quality, and two were rated as fair. EC use is associated with measurable detrimental effects on respiratory health and may negatively affect vocal function. However, evidence regarding phonatory outcomes is still scarce and heterogeneous. Further rigorously designed studies, with standardized assessment protocols and integrated analysis of pulmonary and vocal measures, are necessary to clarify the mechanisms and magnitude of EC-related vocal impairments and to guide clinical and public health recommendations.